Clinical Trial Update: A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee" [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study results for diclofenac sodium gel 1% in knee osteoarthritis have been completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Diclofenac Sodium Gel 1% (diclofenac sodium)

Snippet

Sponsor: Mylan Pharmaceuticals Private Limited | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED | Results posted: 2021-04-20